Jh. Prystowsky et al., PRESENT STATUS OF EYELID PHOTOTHERAPY - CLINICAL EFFICACY AND TRANSMITTANCE OF ULTRAVIOLET AND VISIBLE RADIATION THROUGH HUMAN EYELIDS, Journal of the American Academy of Dermatology, 26(4), 1992, pp. 607-613
Background: Phototherapy for the eyelid has not previously been recogn
ized as a safe and effective treatment of photoresponsive dermatoses o
f the eyelid, such as atopic dermatitis, vitiligo, psoriasis, lymphoma
toid papulosis, and parapsoriasis. Objective: The purpose of this stud
y was to demonstrate the efficacy and safety of this treatment. Method
s: Two cases are presented to demonstrate clinical efficacy. In additi
on, a retrospective eye evaluation of seven patients receiving a combi
ned total of greater than 1300 eyelid phototherapy treatments was perf
ormed. To determine whether potentially harmful UV radiation is signif
icantly transmitted through eyelid skin, an in vitro study was conduct
ed to measure the percentage transmittance of ultraviolet-visible radi
ation through five excised eyelids. Results: In the two cases presente
d, remarkable improvement occurred without adverse side effects, sugge
sting that it is possible to deliver incremental UV dosages to eyelid
skin to achieve clearing of skin disease. Retrospective analysis of pa
tients' records revealed no ocular disease from the phototherapy. In v
itro eyelid examination produced data that indicated negligible quanti
ties of UV radiation were transmitted through eyelid skin compared wit
h the visible spectrum, in which up to 77% of the radiation was transm
itted through the tissue. Conclusion: The combined clinical experience
and transmittance data suggest that eyelid phototherapy is a safe and
effective treatment in selected patients.